👀 Ones to watch: The MOST undervalued stocks to buy right nowSee Undervalued Stocks

U.K. aviation authority probes August air traffic control issues; GSK reduces Haleon stake

EditorHari G
Published 10/06/2023, 04:59 AM
© Reuters.
UK100
-
MSFT
-
ALSO
-
AMZN
-
GSK
-
JDW
-
PNDORA
-

In recent business news, the UK Civil Aviation Authority has launched an investigation into widespread flight disruptions that occurred due to air traffic control issues on August 28. The probe is being led by an independent review panel chaired by Jeff Halliwell.

GlaxoSmithKline (NYSE:GSK) has sold a portion of its stake in Haleon, the world's largest consumer healthcare firm, for £885.6 million. This move reduces GSK's holding in Haleon to 7.4%. The sale is part of GSK's broader strategy to streamline its business and focus on core operations.

JD (NASDAQ:JD) Wetherspoon, a leading pub operator in the UK, has reported a swing to an annual pre-tax profit of £42.6 million. This financial rebound was driven by cost efficiencies and strong demand for the company's competitively priced offerings. Despite concerns about potential lockdowns, JD Wetherspoon's chairman Tim Martin remains optimistic about the company's performance.

In other news, both the FTSE 100 and FTSE 250 have shown growth, with Metro Bank notably rebounding. Investors are closely watching the US non-farm payrolls data for clues on interest rate trends.

Amazon (NASDAQ:AMZN) and Microsoft (NASDAQ:MSFT) are facing a probe by the Competition and Markets Authority (CMA), instigated by Ofcom, due to competition concerns in the UK's cloud computing sector. Meanwhile, Pandora (OTC:PANDY) is enjoying robust sales while HS2 train builder Alstom (EPA:ALSO) is grappling with project delays.

Wealth Club's Charlie Huggins has praised JD Wetherspoon's resilience amidst rising costs and challenging market conditions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.